Search

Afamelanotide is a synthetic alpha-melanocyte-stimulating hormone (alpha-MSH) analog approved by the FDA (as Scenesse) to increase pain-free light exposure in adults with erythropoietic protoporphyria (EPP). It is delivered as a subcutaneous implant and is supported by randomized controlled trials for that indication. It is a prescription product and is not approved for cosmetic tanning.